Growth Strategy for a Major European Animal Nutrition Business with Strategic Expansion into Mexican Animal Feed Market

Growth Strategy for a Major European Animal Nutrition Business with Strategic Expansion into Mexican Animal Feed Market

August 10, 2017
August 10, 2017

Share

AMR (acquired by Stax in 2022) assisted Provimi in making a major strategic move into the Mexican animal feed market.


Client and project overview

Provimi, a major European animal nutrition business, wanted to build a presence in the Mexican market and had identified a potential acquisition target. AMR was asked to provide input on the achievability of the business plan in light of numerous risk factors.


Key questions

  • What is the structure of the Mexican animal feed market and how is it changing (including industrialization)?
  • How have external factors impacted the target’s performance?
  • What are the target’s sources of competitive advantage and how sustainable are there?


Highlights of methodology

  • Developed a sophisticated understanding of the external factors influencing the target’s performance, including underlying demand, industrialization, macro shocks, regional variation and competition
  • We combined this with a thorough review of the target’s internal data (including pricing) and customer base


Results

  • Our work proved critical to allowing the deal to go ahead, based on the key finding that recent volatility in the target’s performance was caused by one-off, external factors and the underlying performance was highly stable
  • Our analysis of customer preferences also identified clear value-creation potential
  • Based on clear recommendations from AMR, the business was able to perform significantly ahead of budget in year one


“The sale of Provimi is the culmination of a four-year project to reshape the business and maximize shareholder value. AMR played a critical role in supporting Provimi as we realized this vision, and helped provide valuable support in the course of a smooth and well-run transaction.” (Provimi)

Read More

Will Barden Named Among The Consulting Report’s Top 25 Strategy Leaders of 2025
By Will Barden December 11, 2025
Will Barden, Partner, has been named among "The Consulting Report's" Top 25 Strategy Leaders of 2025. Click here to read more about the award.
Investing in Pharma Technology: A Healthcare Breakfast Discussion
By Rob Larson & Jordan Abrams December 8, 2025
In partnership with Raymond James and Farragut Square Group, Grant Thornton Stax recently hosted a breakfast event to share our investment analysis of the Pharma Technology market.
Miriam El-Baz & Connor Novy Honored as Consulting Magazine Women Leaders
December 2, 2025
Miriam El-Baz and Connor Novy were recognized at the Consulting Magazine Women Leaders awards to highlight the outstanding contributions made by women in consulting. Read more.
Featured in Financier Worldwide—Accelerating value in PE carve-outs: strategy and execution
By Phil Dunne & Peter Rodrigues-Renon November 11, 2025
Financier Worldwide discusses strategy & execution for accelerating value in carve-outs with Phil Dunne and Peter Rodrigues-Renon at Stax, including Gerard Nichol at Grant Thornton. Read more.
Key Considerations for Investors Exploring the Automotive Retail Tech Value Chain
By Sameer Tejani & Max Massaro November 6, 2025
Investment focus in automotive technology continues to broaden beyond OEMs to the core service ecosystem. Read what Sameer Tejani and Max Massaro see in the market.
Grant Thornton Stax Provides Sell-Side Support to SteelEye on its Merger With FundApps​
November 3, 2025
Grant Thornton Stax supported SteelEye, a leading trade and communications surveillance and data analytics platform, on its recent merger with FundApps. Read about the deal here.
Show More